We are live on ! Find out more
PC

Pavadi Capital Portfolio holdings

AUM $81.2M
1-Year Est. Return 5.26%
This Fund
S&P 500
This Quarter Est. Return
+6.07%
1 Year Est. Return
+5.26%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$81.2M
AUM Growth
+$4.4M
Cap. Flow
+$743K
Cap. Flow %
0.92%
Top 10 Hldgs %
82.59%
Holding
19
New
3
Increased
5
Reduced
6
Closed
5

Top Buys

Rank Stock Value
1
ELV icon
Elevance Health
ELV
+$8.03M
2
ZBH icon
Zimmer Biomet
ZBH
+$6.19M
3
BAX icon
Baxter International
BAX
+$4.65M
4
UNH icon
UnitedHealth
UNH
+$4.03M
5
HCA icon
HCA Healthcare
HCA
+$3.02M

Top Sells

Rank Stock Value
1
PINC
Premier
PINC
+$5.17M
2
CAH icon
Cardinal Health
CAH
+$5.06M
3
INMD icon
InMode
INMD
+$4.73M
4
IART icon
Integra LifeSciences
IART
+$3.82M
5
NVST icon
Envista
NVST
+$3.72M

Sector Composition

Rank Sector Weight
1 Healthcare 100%

No holdings matched the selected filter criteria.

Similar funds

BAM
Broadmark Asset Management San Francisco, California $80.4M AUM 29.98% 1-Year Est. Return
TCM
Tegean Capital Management New York $82.1M AUM 12.91% 1-Year Est. Return
JAM
JLP Asset Management New York $84.2M AUM 10.86% 1-Year Est. Return
HH
HP Holding New York $84.5M AUM 4.73% 1-Year Est. Return
CPI
Canaan Partners IX Menlo Park, California $87.5M AUM
SLM
Snow Lake Management Menlo Park, California $90.7M AUM 72.65% 1-Year Est. Return
AFG
Alterity Financial Group Bangor, Maine $69.9M AUM 40.65% 1-Year Est. Return
TIMH
Tilt Investment Management Holdings New York $92.6M AUM 28.92% 1-Year Est. Return

Pavadi Capital's Q4 2023 Portfolio in Review

As of Q4 2023, Pavadi Capital held 19 positions worth $81.2M, up 5.7% from $76.8M the previous quarter. Its ten largest holdings account for 83% of the portfolio.

Pavadi Capital's Q4 2023 filing shows 3 new, 5 increased, 6 reduced and 5 closed positions. Its largest new stake was Elevance Health: 17,374 shares worth $8.19M. The largest sale was Premier, an estimated $5.17M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Pavadi Capital's largest Q4 2023 buy was Elevance Health: 17,374 shares worth $8.19M.
  • Pavadi Capital added most to UnitedHealth in Q4 2023, an estimated $4.03M increase.
  • Pavadi Capital's biggest Q4 2023 reduction was Lantheus, cutting an estimated $3.06M.
  • Pavadi Capital fully exited Premier in Q4 2023, selling an estimated $5.17M.
  • Pavadi Capital's ten largest holdings make up 83% of its $81.2M portfolio in Q4 2023.
  • Pavadi Capital opened 3 new positions and closed 5 in Q4 2023.
  • Pavadi Capital's portfolio value rose 5.7% quarter-over-quarter to $81.2M.

Based on Pavadi Capital's 13F filing for Q4 2023, filed 14 Feb 2024.